Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > RE: PROFESSIONAL?
View:
Post by ISAloser247 on Jun 26, 2012 12:18pm

RE: PROFESSIONAL?

...am always guessing who 'professional--full of hope" is.  Using the 2012 management information circular as a birdcage liner,  notice that DIRECTOR Prakash Gowd, is listed as Beneficially owning, controlling or directing all of 100,000 Shares.  On the QUOTEMEDIA site, under Insiders,  a Prakash Gowd is shown to have accumulated 650,000 shares from 2 / 18 /11.  to 8 / 03 /11.  550,000 in August 2011, 50,000 on 28 february, 40,000 on 24 february, and 10,000 on february 18 , all in the 2011. ( cash outlay of $101,450 ) Total compensation received by Mr. Gowd for Directorial duties was $86,515. There is obviously, a discrepancy between the ISA circular and the QUOTEMEDIA site, probably , just another 'unresolved issue".
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities